Navigation Links
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Date:9/24/2009

may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

    CONTACT: Amgen, Thousand Oaks
    Christine Regan: 805-447-5476 (media U.S.)
    Wendy Woods: +41 (0) 41 3692 542 (media Europe)
    Arvind Sood: 805-447-1060 (investors)

'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
2. Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer
3. Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
4. In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
5. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
6. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
7. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
8. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
9. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
10. Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL
11. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... Research and Markets( http://www.researchandmarkets.com/research/d85hx9/global_rapid ) has announced the addition ... - Applications and Technologies" report to their offering. ... estimated at US$19.4 billion in 2014, forecast at US$20.4 ... CAGR of 5.7% between 2014 and 2020 to reach ... global market for Rapid Medical Diagnostic Kits (MDKs) has ...
(Date:5/27/2015)... May 27, 2015 E-QURE, Corp. ... engaged in the development and commercialization of its Bio-electrical ... electrotherapy for the noninvasive treatment of hard to heal ... Zacks Small Cap Research http://scr.zacks.com issued a ... According to Zacks, research update, E-QURE Corp "…has a ...
(Date:5/27/2015)... LONDON , May 27, 2015 ... you trends, partnerships, and predicted revenues   ... manufacturing heading? What are the commercial prospects for ... a whole? Visiongain ,s new report shows you ... opportunities and prospects. Our 203 page report ...
Breaking Medicine Technology:Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 2Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 3Global Rapid Medical Diagnostic Kits Market - 2015-2020 Applications and Technologies Analysis of the $27 Billion Industry 4Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 2Zacks Investment Small Cap Research Issues Quarterly Update on E-QURE 3Medical Device Contract Manufacturing Market Forecast 2015-2025 2Medical Device Contract Manufacturing Market Forecast 2015-2025 3Medical Device Contract Manufacturing Market Forecast 2015-2025 4Medical Device Contract Manufacturing Market Forecast 2015-2025 5Medical Device Contract Manufacturing Market Forecast 2015-2025 6Medical Device Contract Manufacturing Market Forecast 2015-2025 7
... Mich., May 15, 2012  InfuSystem Holdings, Inc. (NYSE MKT: ... related services for the healthcare industry, today announced that ... on Monday, May 21, 2012 following the market close.  ... conference call on Tuesday, May 22, 2012 at 9:00 ...
... 15, 2012 /PRNewswire-iReach/ -- Global Information Inc. ... Drug Development: Contract Research Organizations Market ... at the rate of 12% from 2009 to 2010 ... Contract Research Organizations Market to 2018 : Public-Private Partnerships ...
Cached Medicine Technology:Contract Research Organizations Set to Experience Rapid Growth as Development Costs for New Drugs Continue to Rise 2
(Date:5/27/2015)... 2015 Genius Monkey is pleased to ... marketing technology, they have boosted sales for the Utah ... regional level for seven Utah-based dealers. , Until ... and radio media. In 2014 the Utah Honda dealers ... Genius Monkey , shifted their marketing campaigns more ...
(Date:5/27/2015)... May 27, 2015 “Heroin has never been ... our overdoses are coming from,” says Harford County Sheriff Jeff ... May 8th. In the surging heroin related incidents in Baltimore, ... prevention education to prevent heroin addiction and subsequent abuse before ... charge. Drug Rehab Baltimore is a drug and alcohol rehab ...
(Date:5/27/2015)... 2015 SmarterSkin, http://www.smarterskindermatology.com , is taking ... test that makes it easier for patients to find skin ... , Dr. Sejal Shah is a cosmetic dermatologist based in ... offer the test. This revolutionary DNA test uses 16 genetic ... aging: , 1. Firmness and elasticity , 2. ...
(Date:5/27/2015)... Holly CaSaroll, founder of FACE, the award-winning beauty ... cancer. The skin is the body’s largest organ and is ... 3.5 million cases of skin cancer are diagnosed in the ... sun's ultraviolet rays (UVR). , There are several things ... Avoid the sun between the hours of 10 AM and ...
(Date:5/27/2015)... May 27, 2015 The news is ... of lack of compliance documentation or appropriate training: an ... Miami, a propane gas company in Texas and the ... for incidents and accidents due to improper training and ... is proud to introduce the new Supervisor feature which ...
Breaking Medicine News(10 mins):Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 3
... 28 (HealthDay News) -- Rheumatoid arthritis (RA) patients with low ... study finds. Previous research has shown that 13 percent ... associated with worse outcomes. In this new study, researchers ... 466 RA patients and found that 37 percent of them ...
... 28 (HealthDay News) -- Retired professional football players use ... the general U.S. population, a new study shows. ... 1979 and 2006 about their overall health, level of ... prescription pain drugs. Seven percent of the retired ...
... preserve the voice and vocal cord function for patients ... a study from Henry Ford Hospital in Detroit. ... squamous cell carcinomas, offering patients a less invasive option ... the voice," says study co-author Vanessa G. Schweitzer, FACS, ...
... Reporter , FRIDAY, Jan. 28 (HealthDay News) -- People facing ... by lack of control -- with doctors poking and prodding ... Hospice care, however, can give back some control over ... and helping both the dying person and the person,s family ...
... Australian researchers have come one step closer to understanding ... why many common drugs, including some antibiotics, antihistamines and ... It is estimated around 40-50% of all drugs in ... carries electricity in the heart and, as a result, ...
... Thompson HealthDay Reporter , FRIDAY, Jan. 28 (HealthDay News) ... doesn,t mean you die on anyone else,s timetable. Dennis, 91, ... ago, after she was diagnosed with a fatal heart condition. At ... "The illness, the heart condition that I have, is one ...
Cached Medicine News:Health News:Depression in Rheumatoid Arthritis Patients Linked to Social Status 2Health News:Retired NFL Players More Likely to Take Painkillers 2Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 2Health News:Voice-saver: Light therapy for early-stage laryngeal cancer 3Health News:More People Choosing Hospice at Life's End 2Health News:More People Choosing Hospice at Life's End 3Health News:Victor Chang scientists unlock the 'gates' on sudden cardiac death 2Health News:Woman's Life Refutes a Hospice Myth 2
... First Stop absorbable collagen hemostat. FirstStop is ... handling and removal characteristics. It can easily ... fit the wound. FirstStop products are not ... peeled away after hemostasis is achieved. As ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... D-Stat Flowable Hemostat has a thick, ... application, such as vascular access sites ... is also used as an adjunct ... tissue tracts of femoral access sites ...
The D-Stat Radial hemostat band utilizes a compression band together with the active haemostatic material of the D-Stat to control surface bleeding....
Medicine Products: